{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:33:48Z","timestamp":1780680828528,"version":"3.54.1"},"reference-count":36,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background and objectives<\/jats:title><jats:p>Erysipelas, caused by beta\u2010hemolytic streptococci, and limited cellulitis, frequently caused by <jats:italic>Staphylococcus aureus<\/jats:italic> or other bacteria, are skin and soft tissue infections characterized by typical clinical signs. However, despite the therapeutical relevance they are often not differentiated (e.g in clinical trials). Erysipelas are efficiently treated with penicillin, while limited cellulitis is treated with more wide\u2010spectrum antibiotics. This study investigates whether parameters such as CRP, blood counts or novel parameters like immature granulocytes could serve as biomarkers to distinguish between these entities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patients and methods<\/jats:title><jats:p>For this retrospective analysis 163 patients were included. We compared laboratory markers in patients with erysipelas (n\u00a0=\u00a068) to those with limited cellulitis (n\u00a0=\u00a041) of the leg. Both erysipelas and limited cellulitis were defined clinically, with an additional aspect for erysipelas being a prompt response to penicillin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Erysipelas were characterized by higher levels of inflammation. CRP and leukocyte counts are the best parameters to discriminate between both infections. A CRP value \u2265\u00a03.27\u00a0mg\/dl indicated the diagnosis of erysipelas with 75\u00a0% sensitivity and 73.2\u00a0% specificity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results support the thesis that erysipelas and limited cellulitis are distinct infections as defined in the German guidelines and that an assessment of CRP and leukocytes is useful for differential diagnosis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ddg.14252","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T16:44:48Z","timestamp":1602261888000},"page":"1417-1424","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis"],"prefix":"10.1111","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-4246","authenticated-orcid":false,"given":"Christian","family":"Drerup","sequence":"first","affiliation":[{"name":"Department of Dermatology University of Muenster  Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Eveslage","sequence":"additional","affiliation":[{"name":"Institute of Biostatistics and Clinical Research University of Muenster  Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2929-145X","authenticated-orcid":false,"given":"Cord","family":"Sunderkoetter","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology University Hospital Halle (Saale) Martin\u2010Luther\u2010University Halle\u2010Wittenberg  Halle\/Saale Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Ehrchen","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Muenster  Muenster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13790"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1989.01670180051004"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-014-2274-9"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181e8d635"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2019.1606934"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv181"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1989.00390020039008"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1986.00360140113016"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2004.12.010"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268809990483"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800770309"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12721"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01645222"},{"issue":"3","key":"e_1_2_8_15_1","first-page":"334","article-title":"Enqu\u00eate prospective. Erysip\u00e8le et cellulites n\u00e9crosantes: quelle prise en charge en milieu hospitalier?","volume":"128","author":"Schmit JL","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_2_8_16_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry Acute Bacterial Skin and Skin Structure Infections: Developing Drugs for Treatment. 2013. Available fromhttps:\/\/www.fda.gov\/files\/drugs\/published\/Acute\u2010Bacterial\u2010Skin\u2010and\u2010Skin\u2010Structure\u2010Infections\u2010Developing\u2010Drugs\u2010for\u2010Treatment.pdf[Last accessed July 2 2020]."},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.10.008"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.150.9.1907"},{"key":"e_1_2_8_19_1","unstructured":"Paul\u2010Ehrlich\u2010Gesellschaft f\u00fcr Chemotherapie e.V. Kalkulierte parenterale Initialtherapie bakterieller Erkrankungen bei Erwachsenen \u2013 Update 2018. AWMF\u2010Leitlinie. Available fromhttps:\/\/www.awmf.org\/leitlinien\/detail\/ll\/082\u2010006.html[Last accessed July 2 2020]."},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16235"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3001-0"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1985.tb15264.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-011-0126-4"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw463"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2018.1501764"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.213"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.4103\/0255-0857.150891"},{"issue":"5","key":"e_1_2_8_28_1","first-page":"795","article-title":"Delta neutrophil index contributes to the differential diagnosis between acute gout attack and cellulitis within 24 hours after hospitalization","volume":"56","author":"Pyo JY","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2016.28.6.704"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.6197"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.1085"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1086\/678056"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132775"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9371"},{"issue":"6","key":"e_1_2_8_35_1","first-page":"e2754","article-title":"Diagnosing necrotizing fasciitis using procalcitonin and a laboratory risk indicator: brief overview","volume":"10","author":"Zil\u2010E\u2010Ali A","year":"2018","journal-title":"Cureus"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2465"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1086\/421997"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.14252","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ddg.14252","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ddg.14252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T12:23:02Z","timestamp":1692447782000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ddg.14252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["10.1111\/ddg.14252"],"URL":"https:\/\/doi.org\/10.1111\/ddg.14252","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"2020-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}